Miguel-Angel Perales, MD, Memorial Sloan Kettering Cancer Center, New York, NY, provides his highlights from the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), including debates surrounding transplantation versus CAR-Ts in myeloma and lymphoma, the role of measurable residual disease (MRD) in acute myeloid leukemia (AML), maintenance therapy in FLT3-positive AML, and developments in natural killer (NK) cells. This interview took place at COSTEM 2022 in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть